These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30054487)

  • 1. ARD1/NAA10 acetylation in prostate cancer.
    Kuhns KJ; Zhang G; Wang Z; Liu W
    Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
    DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
    Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.
    Wang Z; Wang Z; Guo J; Li Y; Bavarva JH; Qian C; Brahimi-Horn MC; Tan D; Liu W
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3053-8. PubMed ID: 22315407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatility of ARD1/NAA10-mediated protein lysine acetylation.
    Vo TTL; Jeong CH; Lee S; Kim KW; Ha E; Seo JH
    Exp Mol Med; 2018 Jul; 50(7):1-13. PubMed ID: 30054464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
    Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.
    Lee MN; Kweon HY; Oh GT
    Exp Mol Med; 2018 Jul; 50(7):1-11. PubMed ID: 30054454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse roles of arrest defective 1 in cancer development.
    Chaudhary P; Ha E; Vo TTL; Seo JH
    Arch Pharm Res; 2019 Dec; 42(12):1040-1051. PubMed ID: 31813105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
    Magin RS; March ZM; Marmorstein R
    J Biol Chem; 2016 Mar; 291(10):5270-7. PubMed ID: 26755727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
    Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.
    Jaiswal B; Agarwal A; Gupta A
    Front Endocrinol (Lausanne); 2022; 13():886594. PubMed ID: 36060957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxylation of the Acetyltransferase NAA10 Trp38 Is Not an Enzyme-Switch in Human Cells.
    Ree R; Krogstad K; McTiernan N; Jakobsson ME; Arnesen T
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769235
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
    Elife; 2021 Aug; 10():. PubMed ID: 34355692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
    Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
    Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications.
    Lee D; Jang MK; Seo JH; Ryu SH; Kim JA; Chung YH
    Exp Mol Med; 2018 Jul; 50(7):1-12. PubMed ID: 30054466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modification of the androgen receptor in prostate cancer.
    van der Steen T; Tindall DJ; Huang H
    Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.
    Ree R; Geithus AS; Tørring PM; Sørensen KP; Damkjær M; ; Lynch SA; Arnesen T
    BMC Med Genet; 2019 Jun; 20(1):101. PubMed ID: 31174490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis.
    Seo JH; Park JH; Lee EJ; Vo TT; Choi H; Jang JK; Wee HJ; Ahn BJ; Cha JH; Shin MW; Kim KW
    Int J Oncol; 2015 Jan; 46(1):99-106. PubMed ID: 25338643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae.
    Varland S; Arnesen T
    BMC Res Notes; 2018 Jun; 11(1):404. PubMed ID: 29929531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer.
    Lozada EM; Andrysik Z; Yin M; Redilla N; Rice K; Stambrook PJ
    Oncotarget; 2016 Apr; 7(15):20425-39. PubMed ID: 26967250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.
    Van Damme P; Støve SI; Glomnes N; Gevaert K; Arnesen T
    Mol Cell Proteomics; 2014 Aug; 13(8):2031-41. PubMed ID: 24408909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.